Transgenic mice in drug dependence research

Annals of Medicine

Volumn 30, Issue 4, 1998, Pages 390-396

  Pich, Emilio Merlo ^a   Epping Jordan, Mark P ^b  

^a GSK   (Italy)

^b GlaxoSmithKline   (Switzerland)

Author keywords

Acetylcholine nicotinic receptors; Cocaine; Dopamine receptors; Dopamine transporter; Drug dependence; Heroine; Nicotine; Serotonin receptors; Substance abuse; Transgenic mice

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; GENE PRODUCT; NEUROTRANSMITTER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; BINDING SITE; CENTRAL NERVOUS SYSTEM; DRUG DEPENDENCE; EMBRYO DEVELOPMENT; GENE DELETION; GENE MUTATION; MEDICAL RESEARCH; MOTIVATION; MOUSE; NONHUMAN; PATHOGENICITY; PERFORMANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0031717427     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809029939     Document Type: Review

References (46)

1. Thomas KR, Capecchi MR. Site directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503-12.
2. Aguzzi A, Brandner S, Sure U, Ruedi D, Insemann S. Transgenic and knock-out mice: models of neurological disease. Brain Pathology 1994; 4: 3-20.
3. Porter A. Controlling your losses: conditional gene silencing in mammals. Trends Genet 1998; 14: 73-81.
4. Campbell IL, Gold LH. Transgenic modeling of neuropsychiatric disorders. Mol Psychiatry 1996; 1: 105-20.
5. Banbury Conference on Genetic Background in Mice. Mutant mice and neuroscience: recommandation concerning genetic background. Neuron 1997; 19: 755-9.
6. Koob GF. Animal models of drug addiction. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology; The Fourth Generation of Progress. New York: Raven Press; 1995: 759-72.
7. White NM, Hiroi N. Amphetamine conditioned cue preference and the neurobiology of drug seeking. Semin Neurosci 1993; 5: 329-36.
8. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13: 177-84.
9. Di Chiara G. The role of dopamine in drug-abuse viewed form the perspective of its role in motivation. Drug Alcohol Depend 1995; 38: 95-137.
10. Gingrich JA Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993; 16: 299-321.
11. Caine SB, Koob GF. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 1994; 270: 209-18.
12. Caine SB, Heinrichs SC, Coffin VL, Koob GF. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 1995; 692: 47-56.
13. Epping-Jordan MP, Markou A, Koob GF. The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Res 1998; 784: 105-15.
14. Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14: 43-9.
15. Jones SR, Gainetdinov RR, Wightman RM, Garon MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998; 18: 1979-86.
16. White FJ. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur J Pharmacol 1987; 135: 101-5.
17. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-12.
18. Rocha BA, Fumagalli F, Gainetdinov RR, et al. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1998; 1: 132-7.
19. Xu M, Moratalla R, Gold LH, et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994; 79: 729-42.
20. Drago J, Gerfen CR, Westphal H Steiner H. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 1996; 74: 813-23.
21. Xu M, Hu XT, Cooper DC, et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 1994; 79: 945-55.
22. Miner LL, Drago J, Chamberlain PM, Donovan D, Uhl GR. Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport 1995; 6: 2314-6.
23. 1A-deficient mouse. Neuroreport 1997; 8: 2523-7.
24. Caine SB, Gold LH, Koob GF, et al. Intravenous cocaine self-administered in mice: strain differences and effects of D-1 dopamine receptor targeted mutation. Soc Neurosci Abstr 1995; 21: 719.
25. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borelli, E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997; 388: 586-9.
26. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Nat Acad Sci U S A 1996; 93: 1945-9.
27. Xu M, Koeltzow TE, Santiago GT, et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 1997; 19: 837-48.
28. Rubinstein M, Phillips TJ, Bunzow JR, et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine and methamphetamine. Cell 1997; 90: 991-1001.
29. Seeman P, Van Tol HHM. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 264-70.
30. Fumagalli F, Jones S, Bosse R, et al. Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response and pituitary function. Adv Pharmacol 1998; 42: 179-82.
31. Caine SB. Cocaine abuse: hard knocks for the dopamine hypothesis. Nat Neurosci 1998; 1: 90-2.
32. Peltier S, Schenk S. Effects of serotoninergic manipulation on cocaine self-administration in rats. Psychopharmacology 1993; 110: 390-4.
33. Parsons LH, Weiss F, Koob GF. Serotonin 1B receptor stimulation enhances dopamine mediated reinforcement. Psychopharmacology 1996; 128: 150-60.
34. Saudou F, Amara DA, Dierich A, et al. Enhanced aggressive behavior in mice lacking 5HT1B receptor. Science 1994; 265: 1875-8.
35. Rocha BA, Scearce-Levie K, Lucas JJ, et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 1998; 393: 175-8.
36. Hope BT, Nye HE, Kelz MB, et al. Induction of a long lasting AP-1 complex composed of altered Fos-like proteins of brain by chronic cocaine and other chronic treatments. Neurons 1994; 13: 1235-44
37. Merlo Pich E, Pagliusi S, Tessari M, et al. Common neural substrates for the addictive properties of nicotine and cocaine. Science 1997; 272: 83-6.
38. White FJ. Cocaine and the serotonin saga. Nature 1998; 393; 118-9.
39. Crabbe JC, Phillips TJ, Feller DJ, et al. Elevated alcohol consumption in null mutation mice lacking 5-HT1b serotonin receptors. Nat Genet 1996; 14: 98-101.
40. Nisell M, Nomikos GG, Swensson TH. Systemic nicotine-induced dopamine release in the rat nucleus accumbens regulated by nicotinic receptors in the ventral tegmental area. Synapse 1994; 16: 36-44.
41. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nuclaus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255-7.
42. Galzi JL, Changeux JP. Neurotransmitter-gated ion channels as unconventional allosteric protein. Curr Opin Struct Biol 4: 554-65.
43. Corrigal WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine. Psychopharmacology 1992; 107: 285-9.
44. Picciotto MR, Zoli M, Lena C, et al. Abnormal avoidance learning in mice lacking functional high affinity nicotine receptor in the brain. Nature 1994; 374: 65-7.
45. Picciotto MR, Zoli M, Rimondini R, et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 1998; 391: 173-7.
46. Orr-Urtreger A, Goldner FM, Saeki M, et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 1997; 17: 9165-71.